Summary
The drugs used in in vitro fertilisation (IVF) procedures have the ability to stimulate the ovaries either directly or indirectly to cause multiple follicular development. In most centres today combinations of drugs in various regimens are used and a large number of oocytes are obtained for in vitro fertilisation. Despite that, the overall pregnancy rate is still low, and has improved little during the last 5 years. Possible effects of the drugs on the oocyte maturation process and the endocrinology of the menstrual cycle may contribute to the low success rate. The recent use of gonadotrophin releasing hormone (GnRH) analogues which block endogenous gonadotrophin secretion, in combination with controlled stimulation of the ovaries with exogenous gonadotrophins, tends to be more successful. However, more suitable protocols for better synchronisation of follicle development and a reduction in the cost of the drugs are required to make in vitro fertilisation a more readily available method for the treatment of infertility.
Similar content being viewed by others
References
Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action — a hypothesis revisited. Fertility and Sterility 42: 331–344, 1984
Angell RR, Templeton AA, Aitken RJ. Chromosome studies in human in vitro fertilisation. Human Genetics 72: 333–339, 1986
Barnes RB, Scommegna A, Schreiber JR. Decreased ovarian response to human menopausal gonadotropin caused by subcutaneously administered gonadotropin-releasing hormone agonist. Fertility and Sterility 47: 512–515, 1987
Bernardus RE, Jones GS, Acosta AA, Garcia JE, Liu H-C, et al. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth. Fertility and Sterility 43: 373–378, 1985
Birkenfeld A, Navot D, Levi IS, Laufer N, Beier-Hellwig K, et al. Advanced secretory changes in the proliferative human endometrial epithelium following clomiphene citrate treatment. Fertility and Sterility 45: 462–468, 1986
Bomsel-Helmreich D, Huyen LVN, Durand-Gasselin I, Salat-Baroux J, Antoine J-M. Mature and immature oocytes in large and medium follicles after clomiphene citrate and human menopausal gonadotropin stimulation without human chorionic gonadotropin. Fertility and Sterility 48: 596–604, 1987
Buvat J, Marcolin G, Herbaut J-C, Dehaene J-L, Verbecq P, et al. A randomised trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer. Fertility and Sterility 49: 458–461, 1988
Carson RS, Trounson AO, Findlay JK. Successful fertilization of human oocytes in vitro: concentration of oestradiol-17β, progesterone and androstenedione in the antral fluid of donor follicles. Journal of Clinical Endocrinology and Metabolism 55: 798–800, 1982
Chillik CF, Itskovitz J, Hahn DW, McGuire JL, Danforth DR, et al. Characterizing pituitary response to a gonadotropin releasing hormone (GnRH) antagonist in monkeys: tonic follicle-stimulating hormone/luteinizing hormone secretion versus acute GnRH challenge tests before, during and after treatment. Fertility and Sterility 48: 480–485, 1987
Cohen JJ, Debache C, Piglau F, Mandelbum MJ, Plachot M, et al. Sequential use of clomiphene citrate, human menopausal gonadotropin and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Fertility and Sterility 42: 360–365, 1984
Dandekar PV, Martin MC, Glass RH. Polyovular follicles associated with human in vitro fertilization. Fertility and Sterility 49: 483–486, 1988
DeCherney AH, Lavy G. Oocyte recovery methods in in-vitro fertilization. Clinical Obstetrics and Gynecology 29: 171–179, 1986
Diedrich K, Van der Ven H, Al-Hasani S, Krebs D. Ovarian stimulation for in vitro fertilization. Human Reproduction 3: 39–44, 1988
Edwards RG. Human conception in vitro: new opportunities in medicine and research. In Trounson & Wood (Eds) In vitro fertilization and embryo transfer, pp. 217–250, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1984
Edwards RG, Fishel SB, Cohen J, Fehilly CB, Purdy JM, et al. Factors influencing the success of in vitro fertilization for alleviating human infertility. Journal of In Vitro Fertilization and Embryo Transfer 1: 3–23, 1984
Edwards RG, Steptoe PC, Purdy JM, Establishing full term human pregnancies using cleaving embryos grown in vitro. British Journal of Obstetrics and Gynaecology 87: 737–756, 1980
Eibschitz I, Belaisch-Allart JC, Frydman R. In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge. Fertility and Sterility 45: 231–236, 1986
Ferraretti AP, Garcia JE, Acosta AA, Jones G. Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women. Fertility and Sterility 40: 742–747, 1983
Fleming R, Coutts JRT. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertility and Sterility 45: 226–230, 1986
Fleming R, Hamilton MPR, Haxton MJ, Coutts JRT. Blockade of the LH surge and direct control of ovarian function in women with functioning pituitaries. In Rolland et al. (Eds) Gamete quality and fertility regulation, pp. 197–204, Excerpta Medica, Amsterdam, New York, Oxford, 1985
Fowler RE, Edwards RG, Walters DE, Chan STH, Steptoe PC. Steroidogenesis in preovulatory follicles of patients given human menopausal and chorionic gonadotropins as judged by the radioimmunoassay of steroids in follicular fluid. Journal of Endocrinology 77: 161–169, 1978
Friedler S, Giudice LC, Lamb EJ. Cryopreservation of embryos and ova. Fertility and Sterility 49: 743–764, 1988
Frydman R, Parneix I, Belaish-Allart JC, Forman R, Hazout A, et al. LHRH agonists in IVF: different methods of utilization and comparison with previous ovulation stimulation treatments. Human Reproduction 3: 559–561, 1988
Garcia JE, Jones GS, Acosta AA, Wright Jr GL. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration. Phase I, 1981. Fertility and Sterility 39: 167–173, 1983a
Garcia JE, Jones GS, Acosta AA, Wright Jr GL. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration. Phase II, 1981. Fertility and Sterility 39: 174–179, 1983b
Geier A, Lunenfeld B, Pariente C, Kotev-Emeth S, Shadmi A, et al. Estrogen receptor binding material in blood of patients after clomiphene citrate administration: determination by a radioreceptor assay. Fertility and Sterility 47: 778–784, 1987
Guzick DS, Wilkes C, Jones Jr HW. Cumulative pregnancy rates for in vitro fertilisation. Fertility and Sterility 46: 663–667, 1986
Howies CM, Macnamee MC, Edwards RG. Short term use of an LHRH agonist to treat poor responders entering an in vitro fertilization programme. Human Reproduction 2: 655–656, 1987
Jones GS. Update on in vitro fertilization. Endocrine Reviews 5: 62–75, 1984
Jones GS, Acosta AA, Garcia JE, Bernardus RE, Rosenwaks Z. The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women. Fertility and Sterility 43: 696–702, 1985
Jones GS, Garcia JE, Rosenwaks Z. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human. Journal of Clinical Endocrinology and Metabolism 59: 178–180, 1984a
Jones Jr HW, Acosta AA, Andrews MC, Garcia JE, Jones GS, et al. Three years of in vitro fertilization at Norfolk. Fertility and Sterility 42: 826–834, 1984b
Kenigsberg D, Littman BA, Williams RF, Hodgen GD. Medical hypophysectomy II. Variability of ovarian response to gonadotropin therapy. Fertility and Sterility 42: 116–126, 1984
Kerin JF, Warnes GM. Monitoring of ovarian response to stimulation in in-vitro fertilization cycles. Clinical Obstetrics and Gynaecology 29: 158–170, 1986
Laufer N, DeCherney AH, Haseltine FP, Polan ML, Mezer HC, et al. The use of high dose human menopausal gonadotropin in an in vitro fertilization program. Fertility and Sterility 40: 734–741, 1983
Laufer N, DeCherney AH, Haseltine FP, Polan ML, Tarlatzis BC, et al. Human in vitro fertilization employing individualized ovulation induction by human menopausal gonadotropins. Journal of In Vitro Fertilization and Embryo Transfer 1: 56–62, 1984
Liu JH, Durfee R, Muse K, Yen SSC. Induction of multiple ovulation by pulsatile administration of gonadotropin-releasing hormone. Fertility and Sterility 40: 18–22, 1983
Lopata A. Concepts in human in vitro fertilization and embryo transfer. Fertility and Sterility 40: 289–301, 1983
Lopata A, Brown JB, Leeton JF, McTalbot J, Wood C. In vitro fertilization of preovulatory oocytes and embryo transfer in infertile patients treated with clomiphene and human chorionic gonadotropin. Fertility and Sterility 30: 27–35, 1978
Marrs RP, Vargyas JM, Gibbons WE, Saito H, Mishell Jr DR. A modified technique of human in vitro fertilization and embryo transfer. American Journal of Obstetrics and Gynecology 147: 318–322, 1983
Marrs RP, Vargyas JM, Shangold GM, Yee B. The effect of time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures. Fertility and Sterility 41: 682–685, 1984
McBain JC, Trounson A, Patient management: treatment cycle. In Wood & Trounson (Eds) Clinical in vitro fertilization, pp. 49–65, Springer-Verlag, Berlin, Heidelberg, New York, Tokyo, 1984
McLachlan RK, Robertson DM, Healy DL, de Kretser DM, Burger HG. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF; a new index of follicular function. Lancet 1: 1233–1234, 1986
Messinis IE, Nillius SJ. Comparison between tamoxifen and clomiphene for induction of ovulation. Acta Obstetricia et Gynecologica Scandinavica 61: 377–379, 1982
Messinis IE, Templeton A. The effect of pulsatile follicle stimulating hormone on the endogenous luteinizing hormone surge in women. Clinical Endocrinology 25: 633–640, 1986
Messinis IE, Templeton AA. Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile folliclestimulating hormone. Human Reproduction 1: 11–16, 1987a
Messinis IE, Templeton AA. Relationship between intrafollicular levels of prolactin and sex steroids and in vitro fertilization of human oocytes. Human Reproduction 2: 607–609, 1987b
Messinis IE, Templeton AA. Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. Journal of Reproduction and Fertility 79: 549–554, 1987c
Messinis IE, Templeton A. Blockage of the positive feedback effect of oestradiol during prolonged administration of clomiphene citrate to normal women. Clinical Endocrinology 29: 509–516, 1988a
Messinis IE, Templeton AA. The endocrine consequences of multiple folliculogenesis. Journal of Reproduction and Fertility 36 (Suppl.): 27–37, 1988b
Messinis IE, Templeton A, Angell R, Aitken J. A comparison of fixed regimens for obtaining human cleaving oocytes for research purposes. British Journal of Obstetrics and Gynaecology 93: 39–42, 1986a
Messinis IE, Templeton A, Baird DT. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. Journal of Clinical Endocrinology and Metabolism 61: 1076–1080, 1985
Messinis IE, Templeton AA, Baird DT. Comparison between clomiphene plus pulsatile human menopausal gonadotropin and clomiphene plus pulsatile follicle stimulating hormone in induction of multiple follicular development in women. Human Reproduction 1: 223–226, 1986b
Messinis IE, Templeton A, Baird DT. Endogenous luteinizing hormone surge in women during induction of multiple follicular development with pulsatile follicle stimulating hormone. Clinical Endocrinology 24: 193–201, 1986c
Messinis IE, Templeton A, Baird DT. Relationships between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during superovulation induction in women. Clinical Endocrinology 25: 393–400, 1986d
Messinis IE, Templeton A, Baird DT. Luteal phase after ovarian hyperstimulation. British Journal of Obstetrics and Gynaecology, 94: 345–350, 1987
Oelsner G, Barnea ER, Mullen MV, Mikkelson TJ, Tarlatzis BC, et al. Simultaneous measurements of clomiphene citrate in plasma and follicular fluid in women undergoing IVF and ET. Abstracts of the Conjoint Annual Meeting of the American Fertility Society and the Canadian Fertility and Andrology Society, pp. 14, Toronto, September 27 to October 2, 1986
O’Neill C, Ferrier AJ, Vaughan J, Sinosich MJ, Saunders DM. Causes of implantation failure after in vitro fertilization and embryo transfer. Lancet 2: 615, 1985
Papadopoulos G, Templeton AA, Fisk N, Randall J. The frequency of chromosome anomalies in human pre-implantation embryos after in vitro fertilization. Human Reproduction 4: 91–98, 1989
Plachot M, de Grouchy J, Junca A-M, Mandelbaum J, Salat-Baroux J, et al. Chromosome analysis of human oocytes and embryos: does delayed fertilization increase chromosome imbalance? Human Reproduction 3: 125–127, 1988
Prins GS, Wagner C, Weidel L, Gianfortoni J, Marut EL, et al. Gonadotropins augment maturation and fertilization of human immature oocytes cultured in vitro. Fertility and Sterility 47: 1035–1037, 1987
Quigley MM. The use of ovulation inducing agents in in vitro fertilization. Clinical Obstetrics and Gynaecology 27: 983–992, 1984
Quigley MM, Berkowitz AS, Gilbert SA, Wolf DP. Clomiphene citrate in an in vitro fertilization program: hormonal comparisons between 50 and 150mg daily dosages. Fertility and Sterility 41: 809–815, 1984
Quigley MM, Maklad ND, Wolf DP. Comparison of two clomiphene citrate dosage regimens for follicular recruitment in an in vitro fertilization program. Fertility and Sterility 40: 178–182, 1983
Quigley MM, Schmidt CL, Beauchamp PJ, Maklad NF, Berkowitz AS, et al. Preliminary experience with a combination of clomiphene and variable dosages of menopausal gonadotropins for enhanced follicular recruitment. Journal of In Vitro Fertilization and Embryo Transfer 2: 11–16, 1985
Rainhorn JD, Forman RG, Belaish-Allart J, Hazout A, Fries N, et al. One year’s experience with programmed oocyte retrieval for IVF. Human Reproduction 2: 491–494, 1987
Rosenwaks Z, Muasher SJ. Recruitment of fertilizable eggs. In Jones et al. (Eds) In vitro fertilization Norfolk, pp. 30–51, Williams and Wilkins, Baltimore, London, Los Angeles, Sydney 1986
Russel JB, Polan ML, DeCherney AH. The use of pure folliclestimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program. Fertility and Sterility 45: 829–833, 1986
Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, Margara RA, Franks S, et al. Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinizing hormone releasing hormone. British Medical Journal 296: 1965–1968, 1988
Schenken RS, Hodgen GD. Follicle-stimulating hormone induced ovarian hyperstimulation in monkeys: blockade of the luteinizing hormone surge. Fertility and Sterility 57: 50–55, 1983
Scoccia B, Blumenthal P, Wagner C, Prins G, Scommegna A, et al. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in an in vitro fertilization program. Fertility and Sterility 48: 446–449, 1987
Shaw RW, Ndukwe G, Imoedembe D, Burford G, Chan R. Stimulation of multiple follicular growth for in vitro fertilization by administration of pulsatile luteinizing hormone-releasing hormone during the midfollicular phase. Fertility and Sterility 46: 135–137, 1986
Speirs A, Trounson A, Warner GM, Yovich JL, Saunders DM, et al. Summary of results. In Wood & Trounson (Eds) Clinical in vitro fertilization, pp. 157–163, Springer-Verlag, Berlin, Heidelberg, New York, Tokyo, 1984
Steptoe PC, Edwards RG. Birth after reimplantation of a human embryo. Lancet 2: 366, 1978
Templeton A, Messinis IE, Baird DT. Characteristics of ovarian follicles in spontaneous and stimulated cycles in which there was an endogenous luteinizing hormone surge. Fertility and Sterility 46: 1113–1117, 1986
Templeton A, Van Look P, Lumsden MA, Angell R, Aitken J, et al. The recovery of preovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration. British Journal of Obstetrics and Gynaecology 91: 148–154, 1984
Testart J, Frydman R, DeMouzon J, Lasalle B, Belaish JC. A study of factors affecting the success of human fertilization in vitro. I. Influence of ovarian stimulation upon the number and condition of oocytes collected. Biology of Reproduction 15: 415–424, 1983
Thatcher SS, Donachie KM, Glasier A, Hillier SG, Baird DT. The effects of clomiphene citrate on the histology of human endometrium in regularly cycling women undergoing in vitro fertilization. Fertility and Sterility 49: 296–301, 1988
Trounson AO, Leeton JF, Wood C, Webb J, Wood J. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 212: 681–682, 1981
Tsonis CG, Messinis IE, Templeton AA, McNeilly AS, Baird DT. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. Journal of Clinical Endocrinology and Metabolism 66: 915–921, 1988
Tureck R, Mastroianni Jr L, Blasio L, Strauss III JF. Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. Journal of Clinical Endocrinology and Metabolism 54: 1078–1080, 1982
Vargyas JM, Morente C, Shangold C, Marrs RP. The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo replacement. Fertility and Sterility 42: 745–749, 1984
Wang T-A, Armant DR, Taymor ML, Seibel MM. The influence of exogenous human chorionic gonadotropin cycles with spontaneous luteinizing hormone surges on the outcome of in vitro fertilization. Fertility and Sterility 48: 613–616, 1987
Wildt L, Diedrich K, Van der Ven H, Hasani SAL, Hubner H, et al. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Human Reproduction 1: 15–19, 1986
Wood C, Johnston I. Selection of patients. In Wood & Trounson (Eds) Clinical in vitro fertilization, pp. 27–36, Springer-Verlag, Berlin, Heidelberg, New York, Tokyo, 1984
Wood C, McMaster R, Rennie G, Trounson A, Leeton J. Factors influencing pregnancy rates following in vitro fertilization and embryo transfer. Fertility and Sterility 43: 245–250, 1985
Yee B, Vargyas JM. Multiple follicle development utilizing combinations of clomiphene citrate and human menopausal gonadotropins. Clinical Obstetrics and Gynecology 29: 141–147, 1986
Yoshimura Y, Hosoi H, Atlas SJ, Adashi T, Sautulli R, et al. Estradiol reverses the limiting effects of clomiphene citrate on early embryonic development in the in vitro perfused rabbit ovary. Fertility and Sterility 48: 1030–1035, 1987
Yuen BH, Pride SM, Rowe TC, Moon YS, McComb PF, et al. Comparison of the outcome of ovulation induction therapy in an in vitro fertilization program employing a low-dose and an individually adjusted high-dose schedule of human menopausal gonadotropins. American Journal of Obstetrics and Gynecology 151: 172–175, 1985
Zorn JR, Barata M, Brami C, Epelboin S, Natham C, et al. Ovarian stimulation for in vitro fertilization combining administration of gonadotropins and blockade of the pituitary with DTrp6-LHRH microcapsules: pilot studies with two protocols. Human Reproduction 3: 235–239, 1988
Zorn JR, Boyer P, Guichard A. Never on a Sunday: programming for IVF-ET and GIFT. Lancet 1: 385–386, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Messinis, I.E. Drugs Used in In Vitro Fertilisation Procedures. Drugs 38, 148–159 (1989). https://doi.org/10.2165/00003495-198938010-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198938010-00006